Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Weekly
Analytics
Project Updates and Milestones news
(page 3)
19 February 2026
Johnson & Johnson's Rybrevant Faspro™ Shows 56% Response Rate in First-Line Head and Neck Cancer
The OrigAMI-4 study shows amivantamab with immunotherapy offers durable antitumor activity in recurrent/metastatic head and neck cancer, improving outcomes over current treatments.
19 February 2026
Trinseo's Rho Plant Achieves ISO 9001 Certification
The Rho facility's ISO 9001:2015 certification highlights its quality management and ability to produce high-quality recycled monomers. Other Trinseo sites also hold this certification.
19 February 2026
Statkraft's Former Employees Advance Biofuel Tech at Tofte
Statkraft shifts focus to core technologies, transferring biofuel expertise to a new company led by former employees, aiming to commercialize HTL technology for emissions reduction.
19 February 2026
Merck Reports Positive Phase 3 Trial Results for ENFLONSIA in High-Risk Infants and Children
ENFLONSIA shows consistent safety and efficacy in high-risk infants over two RSV seasons, supporting expanded use for children under 2.
19 February 2026
AGC Biologics Gains Anvisa GMP Certification for Seattle Facility
The Seattle site can now supply biopharmaceuticals to Brazil, enhancing AGC's global supply capabilities and expanding regulatory approvals to over 11 countries.
19 February 2026
Asahi Kasei's Thin-Film Hall Elements Earn IEEE Milestone Recognition
Thin-film Hall elements, launched in 1983, revolutionized magnetic sensors, enhancing electronics and energy efficiency, with over 50 billion units shipped globally.
News type
New Projects and Expansions
New Projects and Expansions
Project Updates and Milestones
Project Updates and Milestones
Mergers, Acquisitions, and Partnerships
Mergers, Acquisitions, and Partnerships
Innovation and Product Development
Innovation and Product Development
Operational Changes and Investments
Operational Changes and Investments
Sustainability and Environmental Initiatives
Sustainability and Environmental Initiatives
Financial Performance and Strategy
Financial Performance and Strategy
Executive Appointments and Governance Changes
Executive Appointments and Governance Changes
Regulatory and Compliance Updates
Regulatory and Compliance Updates
Workforce and Corporate Social Responsibility (CSR)
Workforce and Corporate Social Responsibility (CSR)
Crisis and Risk Management
Crisis and Risk Management
The right choices in the European chemical industry
Save time with
chemXplore Analytics
Learn more
18 February 2026
AFC Energy Gains Approval to Export and Sell Low Carbon Hydrogen from Ammonia Cracking Plant
The UK Environment Agency's permit revision allows hydrogen production training at Dunsfold and supports future deployments with Industrial Chemicals Group Ltd.
18 February 2026
Asahi Kasei Pharma Advances AK1960 to Phase I for Refractory Diseases
AK1960, an ETA receptor antagonist, enters Phase I trials for refractory diseases, leveraging Alchemedicine's HiSAP™ platform and partnerships with Calliditas and Veloxis.
18 February 2026
Johnson & Johnson's RYBREVANT FASPRO™ Gains FDA Breakthrough Status for Advanced Head and Neck Cancer
FDA grants Breakthrough Therapy Designation to RYBREVANT FASPRO™ for HPV-unrelated head and neck cancer after platinum-based chemotherapy and PD-1/PD-L1 inhibitor.
18 February 2026
Baltic Power Completes Foundation Installation for Offshore Wind Farm
All 78 monopile foundations are installed at Poland's first offshore wind farm, with electricity set to be supplied by year-end. Construction completion is expected in late 2026.
18 February 2026
Lilly's Taltz and Zepbound Show Superior Results in Psoriasis and Obesity Trial
Taltz and Zepbound together improved skin clearance and weight loss in psoriasis patients with obesity, outperforming Taltz alone in a Phase 3b trial.
18 February 2026
VolagHy Releases EIA Program for Kuopio Site
The EIA program for the Kuopio site outlines environmental, social, and land-use assessments, moving the project into the formal evaluation phase with stakeholder engagement.
17 February 2026
Novo Nordisk: EU Approves Higher Wegovy® Dose for Obesity, 21% Average Weight Loss
The EU approved a 7.2 mg Wegovy® dose for obesity. In studies, participants lost 21% body weight on average. Common side effects: nausea, diarrhea, vomiting, and dysaesthesia.
17 February 2026
FDA Approves Johnson & Johnson's Monthly EGFR Therapy RYBREVANT FASPRO
FDA approves monthly dosing for RYBREVANT FASPRO, maintaining efficacy and reducing administration time and reactions compared to bi-weekly and IV schedules for EGFR-mutated NSCLC treatment.
17 February 2026
ElevenEs Secures Series B Funding with Caterpillar Venture Capital
ElevenEs to start building a 1GWh LFP battery factory in Serbia, aiming for 2027 deliveries, creating 350 jobs, and advancing European battery tech.
17 February 2026
Neste and World Fuel Services Expand SAF Availability at 100+ European Airports
The five-year agreement supports regulatory compliance and boosts SAF supply, leveraging World Fuel's network and Neste's production capabilities.
17 February 2026
ORLEN's Largest Investment Program
PLN 380 billion will modernize Poland's energy system, focusing on gas security, renewables, and grid expansion, ensuring secure, affordable energy.
17 February 2026
Worley Advises on New Zealand LNG Terminal
Worley provides technical support for New Zealand's LNG terminal, ensuring international standards and local compliance, from procurement to commissioning.
16 February 2026
Lilly's Retevmo Shows Event-Free Survival Benefit in Early-Stage RET Fusion-Positive Lung Cancer
Selpercatinib significantly reduces disease recurrence risk in early-stage RET fusion-positive NSCLC. Safety profile aligns with previous trials. Detailed results pending.
16 February 2026
Eni Discovers Gas and Condensate in Côte d'Ivoire's Calao Channel
Murene South-1X well in Block CI-501 confirms significant gas and condensate potential in Côte d'Ivoire, with estimated volumes of 5.0 Tcf gas and 450 million barrels of condensate.
16 February 2026
Chevron Secures Four Offshore Leases for Greek Exploration
Chevron and HELLENiQ ENERGY sign agreements for offshore exploration in Greece, focusing on seismic work to assess hydrocarbon potential. Awaiting Greek Parliament ratification.
16 February 2026
Roche Reports Positive Phase III Results for Gazyva in Membranous Nephropathy
Phase III study shows Gazyva achieves higher remission rates in membranous nephropathy, with safety consistent and no new signals. Data to be shared with health authorities.
15 February 2026
Genentech's Gazyva Shows Positive Phase III Results in Primary Membranous Nephropathy
Phase III study shows Gazyva achieves significant remission in primary membranous nephropathy, with safety profile consistent and no new signals. Data to be shared with health authorities.
14 February 2026
Eni Announces Major Oil Find in Angola's Algaita-01
The Algaita-01 well in Block 15/06, offshore Angola, reveals 500 million barrels of oil, with existing infrastructure boosting development potential.
13 February 2026
SkyNRG Begins Construction of First SAF Plant in the Netherlands
The plant will produce 100,000 tonnes of SAF annually, cutting GHG emissions by up to 90%. KLM is the main off-taker. Construction follows a seven-year development phase. Completion is due in 2028.
13 February 2026
ASPİLSAN Enerji Hosts SAFELOOP Project Meeting in Kayseri
The SAFELOOP Project focuses on enhancing battery sustainability and recycling, uniting 15 organizations to improve lithium-ion battery safety and performance.
13 February 2026
Sinopec's Natural Gas Power Project Connects to Grid
Sinopec's project uses natural gas pressure differences for power, generating over 10,000 kWh by Feb 12, reducing costs and enhancing energy efficiency with intelligent control systems.
13 February 2026
Elkem Q4 2025: Market Challenges Offset by Cost Improvements; Silicones Division Sale
EBITDA fell 24% YoY. Silicones sale to Bluestar boosts focus and flexibility. Safety incident in Lyon. Market uncertainties persist, but strong cost positions aid adaptation.
12 February 2026
Tengizchevroil 2025 Business Results
In 2025, $10.6B was paid to Kazakhstan. Crude oil output rose by 12M tons. Air emissions cut by 78% since 2000. 71% local content achieved. Social programs benefited 10,000 in Atyrau.
12 February 2026
Tengizchevroil 2025 Performance Highlights
In 2025, $10.6B paid to Kazakhstan, crude oil output rose, emissions cut by 78%, 71% local content achieved, and social programs benefited 10,000 in Atyrau.
← Previous
Next →
